Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · IEX Real-Time Price · USD
34.98
-1.31 (-3.61%)
At close: Jul 2, 2024, 4:00 PM
35.36
+0.38 (1.09%)
After-hours: Jul 2, 2024, 6:47 PM EDT
Apellis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for APLS stock have an average target of 72.71, with a low estimate of 46 and a high estimate of 106. The average target predicts an increase of 107.86% from the current stock price of 34.98.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 31, 2024.
Analyst Ratings
The average analyst rating for APLS stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 9 | 9 | 9 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 18 | 18 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Initiates $46 | Hold | Initiates | $46 | +31.50% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $92 | Strong Buy | Reiterates | $92 | +163.01% | May 28, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $57 → $48 | Hold | Maintains | $57 → $48 | +37.22% | May 23, 2024 |
| Needham | Needham | Strong Buy Reiterates $85 | Strong Buy | Reiterates | $85 | +143.00% | May 8, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $67 → $60 | Strong Buy | Maintains | $67 → $60 | +71.53% | May 8, 2024 |
Financial Forecast
Revenue This Year
835.47M
from 396.59M
Increased by 110.66%
Revenue Next Year
1.21B
from 835.47M
Increased by 44.47%
EPS This Year
-1.07
from -4.45
EPS Next Year
1.12
from -1.07
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.0B | 1.8B | 2.7B | 2.6B | 2.9B |
| Avg | 835.5M | 1.2B | 1.7B | 1.9B | 2.2B |
| Low | 750.6M | 928.2M | 1.1B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 153.9% | 109.5% | 121.6% | 58.2% | 50.2% |
| Avg | 110.7% | 44.5% | 38.7% | 13.6% | 13.2% |
| Low | 89.3% | 11.1% | -7.4% | -19.2% | -19.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.21 | 4.29 | 7.06 | 8.75 | 10.30 |
| Avg | -1.07 | 1.12 | 3.62 | 5.11 | 5.93 |
| Low | -1.47 | -0.86 | 0.03 | 2.62 | 3.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 531.1% | 141.8% | 101.8% |
| Avg | - | - | 223.5% | 41.1% | 16.3% |
| Low | - | - | -97.4% | -27.7% | -23.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.